These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16228913)

  • 1. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
    Esler M; Kaye D
    Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.
    Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD
    J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse consequences of high sympathetic nervous activity in the failing human heart.
    Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
    J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional sympathetic effects of low-dose clonidine in heart failure.
    Aggarwal A; Esler MD; Morris MJ; Lambert G; Kaye DM
    Hypertension; 2003 Mar; 41(3):553-7. PubMed ID: 12623958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension.
    Esler M
    Exp Physiol; 2011 Jul; 96(7):611-22. PubMed ID: 21551268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
    Azevedo ER; Newton GE; Parker JD
    J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
    Rundqvist B; Elam M; Bergmann-Sverrisdottir Y; Eisenhofer G; Friberg P
    Circulation; 1997 Jan; 95(1):169-75. PubMed ID: 8994433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiadrenergic effect of chronic amiodarone therapy in human heart failure.
    Kaye DM; Dart AM; Jennings GL; Esler MD
    J Am Coll Cardiol; 1999 May; 33(6):1553-9. PubMed ID: 10334423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac sympathetic nerve activity in ischemic heart failure].
    Richardt G; Hartmann F; Slotty C; Katus HA
    Z Kardiol; 1998; 87 Suppl 2():33-6. PubMed ID: 9827459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autonomic nervous system in congestive heart failure.
    Francis GS; Cohn JN
    Annu Rev Med; 1986; 37():235-47. PubMed ID: 2871803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.